Mednet Logo
HomeGynecologic OncologyQuestion

Would you consider maintenance therapy in a recurrent endometrial cancer that is MSI-H and ER/PR+ that achieved a complete response after pelvic RTx and 4 cycles of Carbo/Taxol?

1 Answers
Mednet Member
Mednet Member
Gynecologic Oncology · Legacy Health System

Great question! Before answering, we must first answer the pivotal question: is there maintenance therapy that has been demonstrated to be beneficial for such a patient? (e.g. endometrial cancer patient after an excellent response to radiation and chemotherapy for recurrent disease)? If so, are thos...

Register or Sign In to see full answer

Would you consider maintenance therapy in a recurrent endometrial cancer that is MSI-H and ER/PR+ that achieved a complete response after pelvic RTx and 4 cycles of Carbo/Taxol? | Mednet